Intelligent Bio Solutions Inc. (NASDAQ:INBS – Get Free Report) saw a large increase in short interest in the month of August. As of August 15th, there was short interest totalling 148,300 shares, an increase of 3,123.9% from the July 31st total of 4,600 shares. Based on an average trading volume of 57,400 shares, the days-to-cover ratio is presently 2.6 days. Approximately 9.2% of the company’s shares are sold short.
Intelligent Bio Solutions Trading Down 0.5 %
INBS opened at $1.82 on Friday. The business has a fifty day moving average of $2.28 and a 200 day moving average of $3.39. Intelligent Bio Solutions has a 52-week low of $1.38 and a 52-week high of $32.00. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.04 and a current ratio of 0.66.
Hedge Funds Weigh In On Intelligent Bio Solutions
An institutional investor recently bought a new position in Intelligent Bio Solutions stock. Sabby Management LLC purchased a new position in shares of Intelligent Bio Solutions Inc. (NASDAQ:INBS – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 126,650 shares of the company’s stock, valued at approximately $367,000. Intelligent Bio Solutions makes up approximately 0.3% of Sabby Management LLC’s holdings, making the stock its 26th biggest holding. Sabby Management LLC owned approximately 8.52% of Intelligent Bio Solutions at the end of the most recent quarter. 42.57% of the stock is owned by institutional investors and hedge funds.
Intelligent Bio Solutions Company Profile
Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
Further Reading
- Five stocks we like better than Intelligent Bio Solutions
- What is the Death Cross and How Can Investors Use it For Successful Trading?
- 2 Stocks to Get You Ready for the Holiday Season
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Profit Potential: 5 Undervalued Stocks With High Dividend Yields
- How to Invest in Blue Chip Stocks
- MarketBeat Week in Review – 8/21 – 8/25
Receive News & Ratings for Intelligent Bio Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Bio Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
